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The glutamatergic regulation of 5-HT neuronal activity has not been extensively 
studied.  Here we used extracellular single unit recording in midbrain slices to 
examine glutamate receptor mediated effects on 5-HT neuronal activity in the dorsal 
(DRN) and the median raphe nuclei (MRN). 
Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) (1 and 3 mM) 
concentration-dependently increased firing in 5-HT neurones in both the DRN and the 
MRN.  The response to AMPA was blocked by the AMPA receptor antagonist, 6,7-
dinitroquinoxaline-2,3(1H-4H)-dione (DNQX) (10 mM), but not the N-methyl-D-
aspartate (NMDA) receptor antagonist, 2-amino-5-phosphonopentanoic acid (AP-5) 
(50 mM).  NMDA (10-100 mM) also increased 5-HT neuronal firing in a 
concentration-dependent manner in both the DRN and MRN: a response which was 
blocked by AP-5 (50 mM).  In some DRN neurones the NMDA response was partially 
antagonised by DNQX (10 mM) suggesting that NMDA, as well as directly activating 
5-HT neurones, evokes local release of glutamate which indirectly activates AMPA 
receptors on 5-HT neurones.  Responses of DRN 5-HT neurones to AMPA and 
NMDA were enhanced by the γ-amino-butyric acid (GABA)A receptor antagonist, 
bicuculline (50 mM), suggesting that both AMPA and NMDA increase local release of 
GABA.  Finally in the DRN the 5-HT1A receptor antagonist, WAY 100635 (100 nM), 
failed to enhance the response of 5-HT neurones to AMPA and caused only a small 
increase in the excitatory response to NMDA suggesting a low degree of tonic 
activation of 5-HT1A autoreceptors even when 5-HT neuronal firing rate is high. 
 
Key words: glutamate, extracellular electrophysiology, serotonergic, rat
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Introduction 
The dorsal raphe nucleus and median raphe nucleus (DRN and MRN, respectively) 
are the origin of the 5-hydroxytryptamine (5-HT) innervation of the forebrain.  The 
activity of ascending 5-HT neurones, through forebrain transmitter release, is thought 
to govern a number of physiological functions, and dysfunction in these pathways is 
implicated in the pathophysiology of mood and anxiety disorders.   
 
Functional studies suggest a role for glutamate in the control of 5-HT neuronal 
activity in the midbrain raphe nuclei.  Thus for example, iontophoretic application of 
glutamate has been shown to increase firing activity in 5-HT neurones in the DRN of 
the cat (Levine and Jacobs, 1992).  This effect was completely blocked by kynurenic 
acid suggesting its mediation exclusively through alpha-amino-3-hydroxy-5-methyl-
4-isoxazole propionic acid (AMPA)/kainate receptors.  Consistent with an increase in 
firing activity, local application of glutamate has been shown to increase 5-HT release 
in DRN and/or MRN projection areas (Yoshimoto and McBride, 1992; Lin and Shian, 
1991; Lin and Lin, 1996; Kaehler et al., 1999).  However, it is of note that this 
stimulatory effect on 5-HT release is mimicked by not only AMPA/kainate receptor 
agonists (Lin and Shian, 1991; Lin and Lin, 1996; Tao and Auerbach, 2000), but also 
by agonists selective for N-methyl-D-aspartate (NMDA) receptors (Pallotta et al., 
1998; 2001; Tao and Auerbach, 2000).   
 
AMPA receptors have also been shown to mediate excitatory postsynaptic events 
recorded intracellularly in 5-HT neurones in a midbrain slice preparation (Pan and 
Williams, 1989; Jolas and Aghajanian, 1997; Liu et al., 2002).  However, in this 
preparation NMDA was also reported to evoke excitatory effects, as well as inhibitory 
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responses indirectly mediated via γ-amino-butyric acid (GABA)A receptors (Jolas and 
Aghajanian, 1997).   
 
The presence of glutamatergic neurones has been demonstrated within the DRN 
(Roche et al., 2003) as well as in the periaqueductal grey around the DRN (Kalen et 
al., 1985).  In addition to these local glutamate inputs, the DRN and MRN have been 
shown in tracing studies to receive (presumed) glutamatergic innervation from distant 
brain regions including the lateral habenula, lateral hypothalamus, and prefrontal 
cortex (Aghajanian and Wang, 1977; Kalen et al., 1985; Hajós et al., 1998; Peyron et 
al., 1998).   
 
Electrophysiological studies have revealed that in a small proportion of 5-HT 
neurones, stimulation of the prefrontal cortex induces an excitation with a short 
latency characteristic of a monosynaptic connection (Hajós et al., 1998; Celada et al., 
2001).  Interestingly however, the majority of DRN 5-HT neurones respond to 
stimulation of the prefrontal cortex with a poststimulus inhibition (Hajós et al., 1998; 
Celada et al., 2001; 2002; Varga et al., 2001; 2003).  This response has a longer onset 
latency than the excitation suggesting a di-synaptic connection (Hajós et al., 1998; 
Celada et al., 2001; 2002; Varga et al., 2001; 2003).  In line with this the inhibitory 
response has been shown to be dependent on GABAA receptors (Celada et al., 2002; 
Varga et al., 2001) suggesting that it involves activation of GABA interneurones by 
glutamatergic afferents (Hajós et al., 1998; Celada et al., 2002; Varga et al., 2001; 
2003).  However, the glutamate receptor type mediating this effect remains unknown. 
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The aim of this study was to further explore the glutamatergic regulation of 5-HT 
neuronal activity in the raphe nuclei and specifically to determine the direct and 
indirect effects of AMPA and NMDA on the firing activity of 5-HT neurones.   
 
Materials and Methods 
Animals 
Male Lister hooded rats were purchased from Charles River (Kent, UK) and group 
housed under standard conditions of lighting (12h light/dark cycle, lights on 7am), 
temperature (19-21˚C) and humidity (45-55%).  Rats were allowed standard rat chow 
and tap water ad libitum.  All experiments carried out had been reviewed and 
approved by the University of Newcastle Ethical Review Panel and were in 
accordance with the UK Animals (Scientific procedures) act of 1986 and the 
European Community Council Directive of 24th November 1986 (86/609/EEC).  All 
efforts were made to minimize any pain or discomfort of the animals.   
 
Electrophysiological recordings 
For electrophysiological experiments, animals were removed from the home cage and 
rapidly decapitated using a small animal guillotine.  The brain was removed from the 
skull and placed into oxygenated ice-cold sucrose slush (composition (mM): sucrose: 
200, HEPES 10, MgSO4 7, NaH2PO4 1.2, KCl 2.5, NaHCO3 25, CaCl2 0.5, D-glucose 
10, pH 7.4).  The forebrain and cerebellum were removed and the midbrain mounted 
on a Vibratome™ chuck using cyanoacrylate super glue.  Coronal slices (350µm) of 
mid brain containing the DRN and MRN corresponding to plates 47-52 of the Rat 
Brain Atlas (Paxinos and Watson, 1998) were cut in ice-cold sucrose.  Slices were 
transferred to a Petri dish of artificial cerebrospinal fluid (aCSF) (composition (mM): 
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NaCl 124, MgSO4 2.4, KH2PO4 1.25, KCl 3.25, NaHCO3 26, CaCl2 2, D-glucose 10, 
pH 7.4) at room temperature.  Slices were trimmed and a single slice was mounted on 
a bed of lens tissue (Whatman, UK) in an interface perfusion chamber, and perfused 
(0.5 ml/min) with oxygenated aCSF.  Spare slices were maintained in oxygenated 
aCSF in a Petri dish at room temperature for use later the same day.  The bed of the 
perfusion chamber and the aCSF were warmed to 36˚C and an atmosphere of warmed 
humid oxygen (95% O2:5% CO2) was continuously passed over the slice.  To evoke 
firing in the 5-HT neurones recordings from the DRN were made in the continuous 
presence of 1µM phenylephrine and recordings from the MRN were made in the 
presence of 30 µM noradrenaline (Judge et al., 2006). Extracellular recordings were 
made using glass microelectrodes (1.5 or 2.0 mm OD (Clarke Electromedical, 
Reading, UK) 1-3 MΩ in vitro impedance) pulled on a vertical pipette puller 
(Narashige, Japan) and filled with 2M NaCl coloured with Pontamine Sky Blue.  The 
electrode was moved through the slice using a manual micromanipulator.  Signals 
were filtered (50 Hz notch) and amplified (x1000) and were fed via an interface (1401 
or micro1401, CED, Cambridge, UK) to a PC and recorded using Spike2 software 
(version 4, CED, Cambridge, UK).  Putative 5-HT neurones were identified on the 
basis of their electrophysiological characteristics of slow regular firing with broad (»2 
ms) bi- or triphasic action potentials and their inhibitory response to 5-HT (see 
results).  Drugs, diluted in aCSF (containing PE or NA) were applied via the perfusion.  
Agonists were applied for 2 min and antagonists were applied for 3-5 min before, and 
2 min during, reapplication of the agonist.  Several agonist/antagonist drugs were 
tested on each neurone and several neurones were recorded from each slice.  
Appropriate intervals were left between applications of drugs dependent on their wash 
off time determined in pilot studies.  
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Data analysis and statistics 
Firing rates are expressed in Hz (spikes/second) and are given as the mean rate in 
120s periods of interest.  Excitatory responses to agonist drug application are 
expressed as ‘extra spikes’ during the 120s of maximal response relative to the 120s 
period of baseline immediately before application of the drug.  Inhibitory responses to 
5-HT application are expressed as % inhibition (% decrease relative to the firing rate 
in the 120s immediately before the application of the drug).  Means ± SEM (n) are 
quoted.  Differences between responses were assessed using paired t test or Wilcoxon 
signed ranks for non normal data.  Significance at the 5% level is reported.  
 
Drugs and chemicals 
Phenylephrine, noradrenaline, N-methyl-D-aspartate (NMDA), bicuculline, and 5-HT 
were purchased from Sigma, alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic 
acid (AMPA), 6, 7-dinitroquinoxaline-2,3(1H-4H)-dione (DNQX) and 2-amino-5-
phosphonopentanoic acid (AP-5), and phaclofen were purchased from Tocris.  
WAY100635 was a gift of Wyeth-Ayerst.  Other chemicals used were of Analar grade.  
For stock solutions (generally 10 mM), drugs were dissolved in aCSF or distilled 
water except DNQX which was dissolved in dimethylsulfoxide (final concentration 
£1%) and phaclofen which was initially dissolved in 1M NaOH.  Intermediate and 
final dilutions were made in aCSF. 
 
Results 
Neuronal characteristics: DRN 
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Neurones in the DRN which, in the presence of 1 µM phenylephrine, fired slowly and 
regularly with broad action potentials were tested with 5-HT (25-100 µM).  The vast 
majority showed an inhibitory response to 5-HT (25 and/or 50 µM).  Only neurones 
showing an inhibitory response were presumed to be 5-HT neurones.  These DRN 
presumed 5-HT neurones included in the study had a mean basal firing rate in the 
presence of 1 µM phenylephrine of 1.27 Hz (range 0.21-3.22 Hz (101)) and showed a 
mean inhibitory response following the application of 25 µM 5-HT of 59.7 ± 3.1 
(101) %.  Neurones which showed no response or only a small response to 25 µM 
were also tested with 50 µM 5-HT. 
 
Neuronal characteristics: MRN 
In the MRN, neurones which, fired slowly and regularly with broad action potentials 
in the presence of 30 µM noradrenaline were tested with 5-HT (50-100 µM).  The 
vast majority showed an inhibitory response to 5-HT (50 or 100 µM).  Only those 
showing such an inhibitory response were presumed to be 5-HT neurones.  The 30 
MRN presumed 5-HT neurones recorded had a mean basal firing rate in the presence 
of 30 µM noradrenaline of 1.45 Hz (range 0.33-5.53 Hz).  The mean inhibitory 
response following the application of 50 µM 5-HT was 61.7 ± 6.3 (30) %.  Neurones 
which showed no response or only a small response to 50 µM were also tested with 
100 µM 5-HT.  
 
Effect of AMPA on 5-HT neurones  
In all of the presumed 5-HT neurones tested in both the DRN (28) and MRN (12) 
AMPA caused excitation.  The excitatory response took the form of a rapid increase 
in firing activity often with a concurrent decrease in regularity of firing.  Occasionally 
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bursting activity, characterised by groups of action potentials in very rapid succession 
with decreasing interspike interval, was observed (Fig 1A).  In individual 5-HT 
neurones the response to AMPA was concentration dependent.  Thus in the DRN 
application of 1 µM and 3 µM AMPA evoked responses of 192 ± 41.4 and 390 ± 47.9 
(10) extra spikes, respectively (see Fig 1A and Fig 2A) and in the MRN evoked 
responses of 82 ± 25.9 and 306 ± 63.0 (11) extra spikes, respectively (Fig 2A).  
Responses evoked by repeated application of 3 µM AMPA were reproducible (mean 
difference in response: DRN: 6 ± 1.9 (9) extra spikes; MRN: 8 ± 25.9 (4) extra spikes 
(Fig1A and 2B).  
 
Effect of NMDA on 5-HT neurones  
Application of NMDA increased the firing rate in all presumed 5-HT neurones tested 
in both the DRN (82) and the MRN (20).  During the response there was often a 
decrease in regularity of firing and occasional bursting activity was seen (Fig 1B).  In 
individual neurones, the response to NMDA was concentration dependent.  Thus 
applications of 10 and 30 µM NMDA evoked mean responses of 23 ± 8.2 and 156 ± 
28.3 (9) extra spikes in the DRN, and 37 ± 13.3 and 122 ± 24.6 (13) extra spikes in 
the MRN (Fig 2C).  In the DRN some neurones were also tested with 100 µM (e.g. 
Fig 1B): this gave a mean response of 478 ± 136 (5) extra spikes.  Excitations evoked 
by 100 µM NMDA were sometimes followed by a period of inhibition.  Repeated 
application of 30 µM NMDA at ³10 minute intervals gave reproducible responses in 
presumed 5-HT neurones in both the DRN (mean difference: 0.5 ± 8.7 (9) extra spikes) 
and MRN (mean difference: 9.3 ± 9.2 (7) extra spikes) (Fig 2D). 
Effect of excitatory amino acid antagonists on the response to AMPA  
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The selective AMPA/kainate receptor antagonist DNQX (10µM) almost completely 
blocked the excitatory response of presumed 5-HT neurones in the DRN (p<0.001) 
and MRN (p<0.005) to application of AMPA (1 or 3 µM ) (see Table 1 and Fig 3A). 
In contrast to DNQX, the selective NMDA receptor antagonist AP-5 (50 µM) failed 
to influence the excitatory response to application of AMPA (1 or 3 µM) in the DRN 
(see Table 1 and Figure 3B).   
 
Effect of excitatory amino acid antagonists on the responses to NMDA 
AP-5 (50 mM) almost completely blocked the response to NMDA (30 µM) in 
presumed 5-HT neurones in both the DRN (p<0.01) and MRN (p<0.005) (Figure 3C 
and Table 1).  DNQX (10µM) also significantly attenuated the excitation of DRN 
5-HT neurones following application of NMDA (30 µM) (Figure 3D and Table 1) 
although the mean response was reduced by less than 40%.   
 
Effect of GABAA receptor and GABAB receptor antagonists on the response of DRN 
5-HT neurones to AMPA and NMDA 
In the DRN, the responses to AMPA (3 µM) and NMDA (30 µM) were tested in the 
absence and presence of the GABAA receptor antagonist bicuculline (50µM).  
Although the magnitude of the enhancement varied widely between neurones, 
bicuculline significantly enhanced the response to AMPA (p<0.02, Wilcoxon signed 
ranks) (Figure 4A and Table 1).  Bicuculline also significantly enhanced the response 
to NMDA (p<0.01) (Fig 4B and Table 1) as did the GABAB receptor antagonist 
phaclofen (200 mM) (p<0.05 Wilcoxon signed ranks).  Again the effect of phaclofen 
varied greatly between neurones (Fig 4C and Table 1).   
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Effect of 5-HT1A receptor antagonist on the response of DRN 5-HT neurones to AMPA 
and NMDA 
The response to NMDA was slightly but significantly enhanced by the presence of the 
selective 5-HT1A receptor antagonist WAY 100635 (20 nM) (Fig 5A and Table 1).  
However, WAY 100635 failed to alter the excitatory response to AMPA (Fig 5B and 
Table 1) 
 
Effect of antagonists on basal firing in 5-HT neurones of the DRN and MRN 
DNQX alone failed to alter basal firing rate in either the DRN (1.22 ± 0.09 and 1.23 ± 
0.11 (16) Hz, before and during DNQX: n.s.) or the MRN (1.59 ± 0.51 and 1.56 ± 
0.51 (9) Hz, before and during DNQX: n.s.).  AP-5 alone also had no effect on the 
basal firing rate in either the DRN (0.93 ± 0.11 and 0.91 ± 0.13 (18) Hz, before and 
during AP-5: n.s.) or the MRN: 0.46 ± 0.16 and 0.40 ± 0.13 (7) Hz; n.s.).  
 
In the DRN, the basal firing rate of 5-HT neurones was unaffected by bicuculline 
(0.94 ± 0.13 and 1.00 ± 0.14 (19) Hz, before and during bicuculline, n.s.) or phaclofen 
(0.79 ± 0.17 and 0.72 ± 0.26 Hz (6) n.s.).  Finally, WAY100635 alone failed to alter 
basal firing of 5-HT neurones in the DRN (1.07 ± 0.11 and 1.08 ± 0.13 (29) Hz, 
before and during WAY 100635, n.s.). 
 
Discussion 
Here we used extracellular recording to examine the glutamatergic receptor regulation 
of 5-HT neuronal activity.  We found that AMPA caused concentration-dependent 
excitation of 5-HT neurones in the DRN and MRN and that this effect was blocked by 
an AMPA receptor antagonist DNQX but not by an NMDA receptor antagonist, AP-5.  
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The response to AMPA in the DRN, was enhanced by the GABAA receptor antagonist, 
bicuculline, but was unaltered by the 5-HT1A receptor antagonist, WAY 100635.  
NMDA also excited 5-HT neurones in a concentration-dependent manner in both the 
DRN and MRN.  The response to NMDA was blocked by AP-5 and partially 
antagonised by DNQX.  In the DRN the response to NMDA was enhanced in the 
presence of bicuculline and the GABAB receptor antagonist, phaclofen, and was 
slightly increased in the presence of WAY 100635.   
 
5-HT neurones are activated by AMPA 
Here we found that AMPA caused excitation in all presumed 5-HT neurones tested 
and that the responses were concentration-dependent and reproducible showing no 
evidence of AMPA receptor desensitization.  Although a direct comparison between 
DRN and MRN neurones cannot be made due to the use of different perfusion media, 
there were no qualitative differences between 5-HT neurones in the two nuclei with 
respect to sensitivity to AMPA.  The response to AMPA was blocked by the selective 
AMPA/kainate antagonist DNQX but not by the NMDA receptor antagonist AP-5.  
These data suggest that the AMPA response does not involve the local release of 
glutamate (which would be expected to activate NMDA as well as AMPA receptors) 
but rather AMPA acts directly on 5-HT neurones.   
Our data are consistent with previous studies showing AMPA receptor-mediated 
excitation of 5-HT neurones.  In vivo in the cat, AMPA receptors have been shown to 
mediate the effects of iontophoretically applied glutamate as well as the excitatory 
response of 5-HT neurones to sensory stimuli (Levine and Jacobs, 1992).  Thus 
AMPA receptors on 5-HT neurones are probable targets of glutamatergic inputs from 
distant sites.  In the slice preparation AMPA receptors have been shown to mediate 
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excitatory postsynaptic potentials (EPSPs) in 5-HT neurones in the DRN and MRN 
induced by application of neurokinin (Liu et al., 2002) as well as by electrical 
stimulation of the adjacent peri-aqueductal grey (Pan and Williams, 1989; Pinnock, 
1992).  These latter studies suggest that AMPA receptors on 5-HT neurones may also 
be the target of local glutamatergic afferents (see below).   
 
5-HT neurones are excited by NMDA 
All presumed 5-HT neurones tested in both the DRN and the MRN were also excited 
by NMDA.  Responses of 5-HT neurones in the DRN and MRN to NMDA were 
qualitatively similar.  In both nuclei the NMDA responses were concentration-
dependent and reproducible allowing us to examine the effects of antagonists on the 
responses.  As we anticipated, the response to NMDA was blocked by the NMDA 
receptor antagonist AP-5 confirming its mediation through NMDA receptors.  
However (in the DRN) the response to NMDA was also reduced by co-application of 
DNQX.  Although this effect of DNQX was statistically significantly for the neurones 
as a group, examination of individual neuronal responses indicates high variability in 
sensitivity to DNQX.  Indeed, in three of the nine neurones tested the response to 
NMDA was apparently insensitive to DNQX.  In the other neurones DNQX reduced 
the response by between 33 and 85 %.  This variability is in contrast to the effect of 
the same concentration of DNQX on responses to AMPA where excitation was 
reduced by at least 75 % in all neurones tested.  Taken together these data suggest that 
in the DRN, the majority of the response to NMDA is directly mediated but that in 
some neurones, part of the excitatory response is mediated through locally released 
glutamate which acts on AMPA receptors. 
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In a previous study examining excitatory postsynaptic currents (EPSCs) evoked by 
NMDA application to midbrain slice preparations , the authors concluded that NMDA 
acts entirely indirectly through activation of glutamate neurones present in the slice 
(Jolas and Aghajanian, 1997).  However, close examination of the data presented 
reveals that in some neurones at least, NMDA-evoked EPSCs persisted in the 
presence of a selective AMPA antagonist (Jolas and Aghajanian, 1997) suggesting 
direct NMDA effects as we saw here.  Moreover, these authors tested only a relatively 
small number of neurones and it is notable that not all of them responded to NMDA 
with EPSCs suggesting that they may represent a different population than those 
tested in the present study.   
 
Our findings that both AMPA and NMDA increased the firing rate of DRN and MRN 
5-HT neurones is consistent with data from microdialysis studies showing that 
excitatory amino acid receptor agonists increase 5-HT release in terminal areas.  Thus 
for example microinfusion of AMPA into the DRN causes an increase in 5-HT release 
in the nucleus accumbens (Tao and Auerbach, 2000).  Furthermore, intra-DRN 
NMDA increases 5-HT in the hippocampus and nucleus accumbens (Tao and 
Auerbach, 1996) as well as the frontal cortex (Pallotta et al., 1998; 2001), consistent 
with a predominantly excitatory effect of NMDA on 5-HT neuronal firing.  Higher 
concentrations of NMDA have been shown to inhibit forebrain 5-HT release (Pallotta 
et al., 1998; 2001), perhaps a reflection of the inhibition of firing sometimes observed 
here following large excitatory responses to high concentrations of NMDA.   
 
Tonic regulation of 5-HT firing by AMPA and NMDA 
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Whilst AMPA and NMDA consistently increased 5-HT neuronal firing we found that 
neither DNQX nor AP-5 decreased firing activity in the DRN or MRN 5-HT neurones 
in the in vitro slice preparation.  Evidence indicates that in vivo in the anaesthetised 
rat, 5-HT neuronal firing is driven exclusively by a1-adrenoceptor activation (Baraban 
and Aghajanian, 1980).  Moreover, in the unanaesthetized cat, the AMPA antagonist 
kynurenic acid has been shown to be without effect on spontaneous firing during quiet 
wake (Levine and Jacobs, 1992).  However, infusion of AMPA and NMDA receptor 
antagonists into the DRN has been reported to decrease 5-HT release in the forebrain 
in unanaesthetised rats in the dark (active) phase (Tao and Auerbach, 2000).  Tonic 
activity of glutamatergic neurones does not appear to occur in the slice preparation 
possibly because of the removal of long glutamatergic projections and/or excitatory 
afferents to the local glutamate neurones. 
 
Indirect glutamatergic activation of GABAergic neurones 
The excitatory response of 5-HT neurones to both AMPA and NMDA in the DRN 
was enhanced by bicuculline and the response to NMDA was also shown to be 
enhanced by phaclofen.  This finding suggests that NMDA activates local GABAergic 
neurones which in turn tend to inhibit 5-HT neurones via GABAA (and GABAB) 
receptor activation.  We have recently reported that firing in 5-HT neurones in the 
DRN is inhibited by both GABAA and GABAB receptor agonists (Judge et al., 2004).  
Consistent with the present data, NMDA application has been shown to evoke 
bicuculline-sensitive inhibitory postsynaptic events in 5-HT neurones in vitro (Jolas 
and Aghajanian, 1997; Abellan et al., 2000).  Although Abellan and colleagues 
reported no effect of phaclofen on the NMDA-induced inhibitory postsynaptic 
potentials (IPSPs) (Abellan et al., 2000) we found that phaclofen significantly 
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enhanced the excitatory response to NMDA.  This apparent discrepancy may result 
from the fact that the GABAB receptor operates via a G-protein linked K
+ channel and 
induces a later and smaller IPSP than the GABAA IPSPs (Thalmann, 1987).  Our 
present data suggest that AMPA (as well as NMDA) can excite GABAergic neurones 
in the slice preparation and that this increase in GABAergic tone acting through both 
GABAA and GABAB receptors tends to offset the direct excitatory effects of AMPA 
and NMDA on 5-HT neurones. 
 
Glutamatergic inhibition of 5-HT firing 
Whilst there is some consistency in reports that excitatory amino acid receptor 
agonists cause excitation in 5-HT neurones, several groups have reported that 
electrical stimulation of (presumed) glutamatergic afferents to the DRN results in a 
predominantly inhibitory response of 5-HT neurones (Hajós et al., 1998; Celada et al., 
2002; Varga et al., 2001; 2003).  The present data provide support for the mechanism 
advanced by Hajós et al. (1998), and Celada et al. (2002) to explain this latter result.  
Thus, we have shown that both NMDA and AMPA cause indirect activation of 
GABA receptors presumably by activation of NMDA and AMPA receptors on 
GABAergic interneurones in the region of the DRN.  These GABAergic 
interneurones may be the target of glutamatergic afferents from the PFCx and lateral 
habenula.  Some evidence suggests that these GABA neurones are located in the 
lateral periaqueductal grey rather than the DRN itself (Jolas and Aghajanian, 1997).   
 
The role of 5-HT1A receptors in the regulation of 5-HT neuronal activity 
The basal firing rate and excitatory responses to amino acid receptor antagonists were 
examined in the presence of the 5-HT1A receptor antagonist WAY 100635.  We and 
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others have previously observed that this concentration of WAY 100635 (20 nM) 
blocks the 5-HT induced suppression of firing in 5-HT neurones (Johnson et al., 2002; 
Fairchild et al., 2003).  Here, as previously, we found no effect of WAY 100635 
either on basal firing rate or on the AMPA response despite an increase in mean firing 
rate to over 5 Hz.  These data suggest i) that in the slice preparation 5-HT1A receptors 
are not tonically activated at low (basal) or high firing rates and ii) that 
somatodendritic 5-HT release is not elevated by increased firing rate.  Our data 
suggest that 5-HT1A receptor mediated autoinhibition does not function to restrain 
5-HT firing at least in the in vitro slice preparation.  Some evidence indicates that 
5-HT release involved autoinhibition of 5-HT neurones originates from recurrent 
collaterals (Wang and Aghajanian, 1977; Celada et al., 2001) and it should be noted 
that these may be cut in the slice preparation.  Although we found that the response to 
NMDA was enhanced by WAY100635, this effect was small being of the order of 
10%.  Given that the mean firing rate during the NMDA response was around 2.5 Hz 
(i.e. substantially lower than during the AMPA response) it seems unlikely that a 
direct mechanism involving increased firing leading to increased 5-HT release and 
increased 5-HT1A receptor activation, underlies this observation.  It is possible that a 
more indirect mechanism involving other neuronal populations is involved.  
 
Conclusions 
The present data indicate that the firing activity of 5-HT neurones in both the DRN 
and MRN is directly increased by activation of AMPA and NMDA receptors.  Since 
the major response of 5-HT neurones to prefrontal cortex and lateral habenula 
stimulation is inhibition, these receptors are most likely to be the targets of 
glutamatergic afferents from regions other than the prefrontal cortex and lateral 
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habenula.  Local glutamate neurones within the slice preparation can also be activated 
by NMDA to cause indirect excitation of 5-HT neurones.  Our data also indicate that 
local GABA neurones which innervate 5-HT neurones are activated by stimulation of 
AMPA and NMDA receptors.  These GABAergic neurones in the raphe region are 
likely to be the target of glutamatergic projections from the prefrontal cortex and 
lateral habenula.   
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Table 1. 
 DRN MRN 
Agonist Antagonist Before During Before During 
AMPA 
 
DNQX 
(n=7 and 9) 
279 ±  47.6   28 ± 11.4 ** 332 ± 78.4 51 ±  21.9** 
AP-5 
(n=9) 
526 ± 136.4  574 ±131.8 nd nd 
bicuculline (n=12)  
Median and IQ range 
346 
(142.5-603.3) 
426$$  
156.6-803.7 
nd nd 
WAY100635 
(n=10) 
550 ±  44.8 
 
558 ± 44.2 nd nd 
NMDA  
 
DNXQ 
(n=9) 
187 ±  27.8  117 ± 11.2 nd nd 
AP-5  
(n=9 and 7) 
136 ±  27.9   24 ±  3.8** 121 ± 21.2  11 ±  8.7** 
bicuculline 
(n=7) 
174 ±  37.6  291 ± 59.9** nd nd 
phaclofen  
(n=6)  
143 
(135.9-158.1)
186$$ 
150.9-230.1 
nd nd 
WAY100635 
(n=17) 
241 ±  31.2  268 ± 28.5 nd nd 
 
Responses to NMDA and AMPA before and during co-application of antagonists 
drugs expressed as extra spikes.  Data are mean ± s.e.m. (or Median with interquartile 
range).  n.d. indicates not determined. 
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Figure 1.   
Examples of instant frequency plots of recordings from presumed 5-HT neurones in 
the DRN showing excitatory responses to (A) AMPA and (B) NMDA.  Both AMPA 
and NMDA cause excitation which is characterised by a rapid increase in firing rate 
and decrease in regularity.  Part (A) shows that the response to AMPA is 
concentration-dependent (1 and 3 μM) and reproducible.  Part (B) shows the response 
to NMDA is concentration-dependent (10, 30 and 100 μM).  Bars indicate application 
of drugs.  Note: traces have not been corrected for the lag time of the perfusion (2min) 
 25 
 
Figure 2. 
Responses of 5-HT neurones to AMPA and NMDA in the DRN (closed circles) and 
MRN (open circles) are concentration-dependent and reproducibile.  Part (A) shows 
the response to AMPA (1 and 3 mM).  Part (B) shows responses to first and second 
application of AMPA (3 mM). Part (C) shows the response to NMDA 10, 30 and 100 
mM) and part (D) shows the response to first and second application of NMDA (30 
mM).  Neurones were recorded from the DRN (closed circles) and MRN (open 
circles). 
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Figure 3. 
AMPA- and NMDA-evoked excitations in the absence and presence of selective 
AMPA and NMDA receptor antagonists.  Parts (A) and (B) show control response to 
AMPA (1 and 3 mM) and the response recorded during co-application of (A) DNQX 
(10 mM) and (B) AP-5 (50 mM).  Parts (C) and (D) show control response to NMDA 
(30 mM) and the response recorded during co-application of (C) AP-5 (50 mM) and (D) 
DNQX (10 mM).  Neurones were recorded from the DRN (closed circles) and MRN 
(open circles).  See Table 1 for group means and statistical analysis. 
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Figure 4 
AMPA- and NMDA-evoked excitations are enhanced by selective GABAA and 
GABAB receptor antagonists.  Part (A) shows the control response to AMPA (1 and 3 
mM) and the response recorded during co-application of bicuculline (50 mM).  Part (B) 
shows the control response to NMDA (30 mM) and the response recorded during co-
application of bicuculline (50 mM).  Part (C) shows the control response to NMDA 
(30 mM) and the response recorded during co-application of phaclofen (200 mM).  All 
neurones were recorded in the DRN.  See Table 1 for group means and statistical 
analysis.  
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Figure 5 
AMPA- and NMDA-evoked excitations in 
the absence and presence of a selective 
5-HT1A receptor antagonist.  Part (A) shows 
the control response to AMPA (1 and 3 mM) 
and the response recorded during co-
application of WAY 100635 (20 nM).  Part 
(B) shows the control response to NMDA 
(30 mM) and the response recorded during 
co-application of WAY 100635 (20 nM).  
All neurones were recorded in the DRN. See 
Table 1 for group means and statistical 
analysis.  
